nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—conduct disorder	0.115	0.115	CbGpPWpGaD
Amantadine—MAOB—Amine Oxidase reactions—MAOA—conduct disorder	0.0659	0.0659	CbGpPWpGaD
Amantadine—DDC—Amine-derived hormones—CGA—conduct disorder	0.0577	0.0577	CbGpPWpGaD
Amantadine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.0323	0.0323	CbGpPWpGaD
Amantadine—DDC—Dopamine metabolism—COMT—conduct disorder	0.0307	0.0307	CbGpPWpGaD
Amantadine—DDC—Dopamine metabolism—MAOA—conduct disorder	0.0305	0.0305	CbGpPWpGaD
Amantadine—DDC—Biogenic Amine Synthesis—COMT—conduct disorder	0.0274	0.0274	CbGpPWpGaD
Amantadine—DDC—Biogenic Amine Synthesis—MAOA—conduct disorder	0.0272	0.0272	CbGpPWpGaD
Amantadine—DDC—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.026	0.026	CbGpPWpGaD
Amantadine—MAOB—Dopamine metabolism—COMT—conduct disorder	0.0259	0.0259	CbGpPWpGaD
Amantadine—MAOB—Dopamine metabolism—MAOA—conduct disorder	0.0257	0.0257	CbGpPWpGaD
Amantadine—GRIN2C—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0239	0.0239	CbGpPWpGaD
Amantadine—GRIN2D—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0222	0.0222	CbGpPWpGaD
Amantadine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0202	0.0202	CbGpPWpGaD
Amantadine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0201	0.0201	CbGpPWpGaD
Amantadine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0189	0.0189	CbGpPWpGaD
Amantadine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0187	0.0187	CbGpPWpGaD
Amantadine—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0183	0.0183	CbGpPWpGaD
Amantadine—GRIN1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0159	0.0159	CbGpPWpGaD
Amantadine—GRIN2B—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0155	0.0155	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0123	0.0123	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0114	0.0114	CbGpPWpGaD
Amantadine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Amantadine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0102	0.0102	CbGpPWpGaD
Amantadine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00979	0.00979	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00939	0.00939	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00925	0.00925	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0086	0.0086	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00819	0.00819	CbGpPWpGaD
Amantadine—DDC—Amino acid and derivative metabolism—CGA—conduct disorder	0.00803	0.00803	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00799	0.00799	CbGpPWpGaD
Amantadine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00731	0.00731	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00713	0.00713	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—GABRA2—conduct disorder	0.00709	0.00709	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00706	0.00706	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—GABRA2—conduct disorder	0.00659	0.00659	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00616	0.00616	CbGpPWpGaD
Amantadine—MAOB—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00613	0.00613	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.006	0.006	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.006	0.006	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00555	0.00555	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—GABRA2—conduct disorder	0.00541	0.00541	CbGpPWpGaD
Amantadine—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00533	0.00533	CbGpPWpGaD
Amantadine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00497	0.00497	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00477	0.00477	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—GABRA2—conduct disorder	0.00472	0.00472	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.00465	0.00465	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—GABRA2—conduct disorder	0.0046	0.0046	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—SLC6A4—conduct disorder	0.00453	0.00453	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—COMT—conduct disorder	0.00445	0.00445	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00442	0.00442	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD4—conduct disorder	0.00426	0.00426	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00418	0.00418	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—COMT—conduct disorder	0.00414	0.00414	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00411	0.00411	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00391	0.00391	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00359	0.00359	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—COMT—conduct disorder	0.00341	0.00341	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00341	0.00341	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—COMT—conduct disorder	0.0034	0.0034	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—MAOA—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00337	0.00337	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—COMT—conduct disorder	0.00328	0.00328	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—MAOA—conduct disorder	0.00325	0.00325	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0032	0.0032	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—COMT—conduct disorder	0.00317	0.00317	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—MAOA—conduct disorder	0.00315	0.00315	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—COMT—conduct disorder	0.00289	0.00289	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00287	0.00287	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—COMT—conduct disorder	0.0026	0.0026	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—MAOA—conduct disorder	0.00259	0.00259	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00245	0.00245	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00229	0.00229	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—COMT—conduct disorder	0.00227	0.00227	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—MAOA—conduct disorder	0.00226	0.00226	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—COMT—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—MAOA—conduct disorder	0.0022	0.0022	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00211	0.00211	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00181	0.00181	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00179	0.00179	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.0016	0.0016	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00155	0.00155	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00154	0.00154	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00153	0.00153	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00148	0.00148	CbGpPWpGaD
Amantadine—DDC—Metabolism—CGA—conduct disorder	0.00147	0.00147	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—EP300—conduct disorder	0.00147	0.00147	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00132	0.00132	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CGA—conduct disorder	0.00124	0.00124	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—COMT—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—COMT—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000906	0.000906	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000898	0.000898	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000898	0.000898	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000877	0.000877	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000823	0.000823	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000769	0.000769	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000721	0.000721	CbGpPWpGaD
Amantadine—DDC—Metabolism—COMT—conduct disorder	0.000666	0.000666	CbGpPWpGaD
Amantadine—DDC—Metabolism—MAOA—conduct disorder	0.000661	0.000661	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CGA—conduct disorder	0.000659	0.000659	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EP300—conduct disorder	0.000617	0.000617	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CGA—conduct disorder	0.000614	0.000614	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EP300—conduct disorder	0.000601	0.000601	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000586	0.000586	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000581	0.000581	CbGpPWpGaD
Amantadine—MAOB—Metabolism—COMT—conduct disorder	0.00056	0.00056	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MAOA—conduct disorder	0.000556	0.000556	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000507	0.000507	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CGA—conduct disorder	0.000486	0.000486	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD4—conduct disorder	0.000461	0.000461	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—WASF1—conduct disorder	0.00039	0.00039	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000375	0.000375	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CGA—conduct disorder	0.00036	0.00036	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	0.000331	0.000331	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	0.000301	0.000301	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—COMT—conduct disorder	0.000297	0.000297	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000295	0.000295	CbGpPWpGaD
Amantadine—DDC—Metabolism—EP300—conduct disorder	0.000286	0.000286	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—COMT—conduct disorder	0.000277	0.000277	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000275	0.000275	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD4—conduct disorder	0.000272	0.000272	CbGpPWpGaD
Amantadine—MAOB—Metabolism—EP300—conduct disorder	0.00024	0.00024	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—conduct disorder	0.000178	0.000178	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—COMT—conduct disorder	0.000162	0.000162	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MAOA—conduct disorder	0.000161	0.000161	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—EP300—conduct disorder	0.000128	0.000128	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—EP300—conduct disorder	0.000119	0.000119	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EP300—conduct disorder	9.41e-05	9.41e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—EP300—conduct disorder	6.97e-05	6.97e-05	CbGpPWpGaD
